Dr. Julie McDonald graduated from the University of Guelph (Guelph, Canada) with a PhD in Molecular and Cellular Biology (2013) where her thesis research focused on developing and validating a twin-vessel single-stage chemostat model of the human distal gut (nicknamed the "Robogut").
During her previous postdoctoral position at Queen's University (Kingston, Canada) she continued using the Robogut system to investigate gut microbial community dynamics in different healthy donors used for stool transplants for Clostridium difficile infection.
Her previous project at Imperial College London was investigating the role of microbially produced enzymes in the establishment and maintenance of Clostridium difficile infection using a Robogut model.
Her current project is investigating the microbial and metabolic profiles of the gut microbiome in autism, including dynamic responses to therapy. This project is supported by the Kristian Gerhard Jebsen Foundation.